Latest Leverage News

Ridley Corporation reports solid FY25 earnings growth and outlines a diversified growth strategy for FY26, anchored by its recent Incitec Pivot Fertilisers acquisition.

Enegex Limited has completed its acquisition of Famien Resources and appointed Paul Roberts as Managing Director, signaling a strategic shift aimed at accelerating gold exploration efforts.

SportsHero has officially launched its HeroPlay mobile gaming platform in Indonesia through a partnership with Indosat Ooredoo Hutchison, offering over 600 instantly playable HTML5 games to nearly 99 million potential users.

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.

OMG Group has inked a five-year exclusive distribution agreement with SANDAI, a premium Japanese matcha producer, positioning itself to capture significant growth in Australia’s expanding matcha market.

Cyclopharm Limited reaffirms its ambitious target of 250–300 US Technegas installations by late 2026, driven by FDA approval, CMS reimbursement, and a growing pipeline of healthcare sites. The company reports record half-year revenue growth, signaling strong momentum in the expanding lung imaging market.

Aquirian Limited is accelerating its growth trajectory through strategic joint ventures and a major expansion of its Wubin facility, aiming to reshape the mining services landscape with advanced drill and blast technologies.

DevEx Resources has appointed Marnie Finlayson, a seasoned mining executive from Rio Tinto, as Managing Director starting December 2025, signaling a strategic push in uranium and rare earth projects.

Rent.com.au has seen option holders exercise over $4 million early, injecting significant growth capital and accelerating its path to profitability.

Nufarm reported a mixed FY25 with strong crop protection profits offset by a statutory loss from seed restructuring, while targeting earnings growth and debt reduction in FY26.

Nufarm’s FY25 results reveal robust growth in crop protection and a strategic shift in seed technologies, alongside a significant $538 million reduction in net debt. The company eyes stronger earnings and lower leverage in FY26.

Nufarm Limited reported a $165.3 million statutory loss for FY25, driven by restructuring costs in Seed Technologies despite strong Crop Protection growth. A CEO transition and refinancing moves set the stage for FY26.